You saw the reports that Johnson and Johnson can't produce their vaccine until April, even if it shows great effectiveness when they report on their Phase 3 trial this month? Apparently, they are having trouble getting manufacturing set up. Not that surprising, commercializing these processes is hard, but disappointing.
You saw the reports that Johnson and Johnson can't produce their vaccine until April, even if it shows great effectiveness when they report on their Phase 3 trial this month? Apparently, they are having trouble getting manufacturing set up. Not that surprising, commercializing these processes is hard, but disappointing.